Category: Latest News
-
AstraZeneca Shares Slip After HSBC Cuts Rating Following Wainua Setback (AZN)
HSBC Downgrades AstraZeneca to Hold AstraZeneca (NASDAQ:AZN) shares moved lower on Monday after HSBC downgraded the pharmaceutical group to Hold from Buy and reduced its price target to 13,750p from 16,500p, following disappointing Phase 3 results for Wainua. “Wainua setback impairs our bull case, given the more difficult catalyst path ahead,” HSBC analyst Rajesh Kumar…
-
Faraday Future Cuts Nearly 50 Million Warrants and Expands AI Robotics Strategy (FFAI)
Company Reshapes Capital Structure Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI) has canceled a further 5.36 million warrants, bringing the total number eliminated since the end of 2025 to almost 50 million as part of efforts to simplify its capital structure. The company also revised the terms of a financing agreement signed last July, removing most…
-
Micron Shares Slide as Semiconductor Selloff Weighs on Memory Stocks (MU)
Micron Falls in Broad Memory Sector Retreat Micron Technology (NASDAQ:MU) shares dropped 5.1% in premarket trading on Monday to $929.50 as a sharp selloff across the global semiconductor sector weighed heavily on memory-chip manufacturers. The weakness followed a record decline in South Korean rival SK Hynix, whose shares tumbled more than 15% after investors locked…
-
Agenus Shares Rise After Securing Up to $340 Million Financing Package (AGEN)
Private Placement Strengthens Funding Position Agenus Inc. (NASDAQ:AGEN) shares climbed 13% in premarket trading on Monday after the biotechnology company announced an $85 million private placement designed to strengthen its balance sheet and support the continued development of its clinical pipeline. The financing also includes purchase warrants that could generate an additional $255 million if…
-
Q32 Bio Shares Jump 60% After Positive Mid-Stage Alopecia Trial Results (QTTB)
Phase 2 Data Boosts Investor Confidence Q32 Bio Inc. (NASDAQ:QTTB) shares surged 60% on Monday after the biotechnology company announced positive topline results from the 36-week Part B analysis of its SIGNAL-AA Phase 2a study evaluating bempikibart for the treatment of severe and very severe alopecia areata. The encouraging clinical update strengthened investor optimism around…
-
Western Digital Shares Fall as Global Chip Selloff Hits Memory Sector (WDC)
Western Digital Declines in Broad Semiconductor Retreat Western Digital (NASDAQ:WDC) shares fell 5.4% in premarket trading on Monday to $551, as a sharp selloff across global memory and storage stocks weighed on sentiment despite a broadly positive performance in the wider U.S. equity market. The decline followed heavy losses in Asian semiconductor stocks, prompting investors…
-
Tonix Expands TONMYA Medicare Coverage with New Payer Agreement (TNXP)
Medicare Deal Broadens Access to TONMYA Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) has signed a new managed Medicare payer agreement for its fibromyalgia treatment TONMYA® (cyclobenzaprine HCl sublingual tablets), extending the drug’s potential coverage to around 9 million additional Medicare beneficiaries. The agreement is scheduled to become effective on January 1, 2027. U.S. Coverage Expected to…
-
TSMC Delivers Record Second-Quarter Revenue as AI Chip Demand Accelerates (TSM)
AI Boom Drives Record Quarterly Sales TSMC (NYSE:TSM) reported record second-quarter revenue on Monday as robust demand for artificial intelligence chips continued to fuel growth for the world’s largest contract semiconductor manufacturer. Revenue for the April-to-June period climbed 36% year-on-year to T$1.27 trillion (US$39.62 billion), according to Reuters calculations, narrowly exceeding the T$1.264 trillion LSEG…
-
Mastercard Considers Majority Sale of Vocalink as UK Banks Eye Payments Infrastructure (MA)
Mastercard Weighs Options for Vocalink Ownership Mastercard (NYSE:MA) is reportedly considering selling a majority stake in UK payments infrastructure provider Vocalink back to British banks, according to a report by the Financial Times citing people familiar with the matter. The discussions are understood to be at an early stage, with no formal bids or agreements…
-
Stellantis Reports 10% Increase in Second-Quarter Vehicle Shipments as North America Leads Growth
Stellantis (NYSE:STLA) reported preliminary second-quarter vehicle shipments of almost 1.6 million units on Monday, representing a 10% increase compared with the same period last year. The improvement was largely driven by robust demand in North America, while Europe also delivered modest growth following the launch of several new models. North American Sales Deliver Strong Performance…